毛蜕皮素可激活髓系 AMPK,恢复 Lgr5⁺干细胞的稳态,并促进溃疡性结肠炎患者黏膜修复。
Dioscin activates myeloid AMPK to restore Lgr5⁺ stem cell homeostasis and promote mucosal repair in ulcerative colitis
Ni Huang, Shuru Lu, Qiuwei Zhong, Chutian Mai, BeiYang Cong, LongJu Wang, Baoyuan Huang, Bo Liu, Ying Hu, Xiaojun Zhang
Journal:PHARMACOLOGICAL RESEARCH
IF:12.2
DOI:10.1016/j.phrs.2026.108447
PMID:42722241
Published:2026-09-10
research field:免疫代谢天然产物药理学干细胞生物学胃肠病学炎症性肠病巨噬细胞极化
Abstract
Dioscin promotes mucosal regeneration and prevents UC-associated dysplasia. • Dioscin activates myeloid AMPK to suppress inflammatory macrophages. • AMPKα1 is identified as a direct pharmacological target of Dioscin. • Dioscin restores macrophage–ISC crosstalk via IL-1β regulation. • Myeloid AMPK emerges as a therapeutic target for ulcerative colitis. Ulcerative colitis (UC) is a chronic relapsing inflammatory disease with limited efficacy in achieving durable mucosal healing and preventing dysplasia. Macrophage–intestinal stem cell (ISC) crosstalk plays a central role in epithelial regeneration and tumorigenic transition but remains therapeutically underexplored. Here, we show that Dioscin, a natural steroidal saponin from Dioscoreae Rhizoma, alleviates DSS-induced acute colitis and AOM/DSS-induced chronic colitis-associated dysplasia by reprogramming macrophage-dependent ISC homeostasis. Dioscin significantly reduced disease severity, suppressed inflammatory macrophage infiltration, and restored Lgr5⁺ ISC compartments, whereas macrophage depletion abolished these protective effects. In vitro, Dioscin inhibited M1 polarization of LPS/IFN-γ-stimulated macrophages, improved epithelial barrier integrity, and enhanced ISC proliferation in organoid systems via modulation of macrophage-conditioned signaling. Mechanistically, IL-1β was identified as a key macrophage-derived mediator linking inflammatory activation to ISC dysfunction. Importantly, Dioscin directly interacted with catalytic α1 subunit of AMP-activated protein kinase (AMPKα1), activated AMPK/Raptor signaling, and suppressed mTORC1-dependent inflammatory responses, while pharmacological inhibition with Compound C or myeloid-specific deletion of AMPKα1 ( Prkaa1 ᶠˡ/ᶠˡ, nLysM-Cre) abrogated its effects. Collectively, Dioscin ameliorates experimental colitis and dysplasia by activating myeloid AMPK signaling, inhibiting IL-1β-driven macrophage–ISC dysregulation, and restoring epithelial regeneration, highlighti
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


